148 related articles for article (PubMed ID: 36775794)
21. The evidence-base for complementary medicine in children: a critical overview of systematic reviews.
Hunt K; Ernst E
Arch Dis Child; 2011 Aug; 96(8):769-76. PubMed ID: 20605859
[TBL] [Abstract][Full Text] [Related]
22. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
Givens M; Rutherford C; Joshi G; Delaney K
J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
[TBL] [Abstract][Full Text] [Related]
23. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis.
Moody K; Abrahams B; Baker R; Santizo R; Manwani D; Carullo V; Eugenio D; Carroll A
J Pain Symptom Manage; 2017 Jun; 53(6):1026-1034. PubMed ID: 28192225
[TBL] [Abstract][Full Text] [Related]
25. Non-pharmacological pain interventions for sickle cell crisis in pediatrics: A scoping review.
Ibitoye BM; Garrett B; Ranger M; Stinson J
J Pediatr Nurs; 2023; 71():42-54. PubMed ID: 36996737
[TBL] [Abstract][Full Text] [Related]
26. Should acupuncture, biofeedback, massage, Qi gong, relaxation therapy, device-guided breathing, yoga and tai chi be used to reduce blood pressure?: Recommendations based on high-quality systematic reviews.
Niu JF; Zhao XF; Hu HT; Wang JJ; Liu YL; Lu DH
Complement Ther Med; 2019 Feb; 42():322-331. PubMed ID: 30670261
[TBL] [Abstract][Full Text] [Related]
27. Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review.
Ballas SK; Dampier C
Ann Hematol; 2020 Nov; 99(11):2483-2495. PubMed ID: 32852615
[TBL] [Abstract][Full Text] [Related]
28. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
29. The management of sickle cell pain in the emergency department: a priority for health systems.
Po' C; Colombatti R; Cirigliano A; Da Dalt L; Agosto C; Benini F; Zanconato S; Sainati L
Clin J Pain; 2013 Jan; 29(1):60-3. PubMed ID: 22751027
[TBL] [Abstract][Full Text] [Related]
30. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
Peterson EE; Salemi JL; Dongarwar D; Salihu HM
Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
[TBL] [Abstract][Full Text] [Related]
31. A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties.
Chakraborty R; Savani BN; Litzow M; Mohty M; Hashmi S
Cancer; 2015 Jul; 121(14):2303-13. PubMed ID: 25872879
[TBL] [Abstract][Full Text] [Related]
32. Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis.
Houwing ME; Grohssteiner RL; Dremmen MHG; Atiq F; Bramer WM; de Pagter APJ; Zwaan CM; White TJH; Vernooij MW; Cnossen MH
BMC Med; 2020 Dec; 18(1):393. PubMed ID: 33349253
[TBL] [Abstract][Full Text] [Related]
33. Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
Hildenbrand AK; Nicholls EG; Daly BP; Marsac ML; Tarazi R; Deepti R
Postgrad Med; 2014 Mar; 126(2):123-33. PubMed ID: 24685976
[TBL] [Abstract][Full Text] [Related]
34. Chronic pain management in sickle cell disease: A systematic scoping review of controlled trials.
Sidhom D; Aboul-Hassan D; Clauw DJ; Cofield C; Bergmans R
Crit Rev Oncol Hematol; 2023 Oct; 190():104087. PubMed ID: 37541536
[TBL] [Abstract][Full Text] [Related]
35. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
36. Total Hip Arthroplasty in Patients With Sickle Cell Disease: A Comprehensive Systematic Review.
Fassihi SC; Lee R; Quan T; Tran AA; Stake SN; Unger AS
J Arthroplasty; 2020 Aug; 35(8):2286-2295. PubMed ID: 32376165
[TBL] [Abstract][Full Text] [Related]
37. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.
Blinder MA; Duh MS; Sasane M; Trahey A; Paley C; Vekeman F
J Emerg Med; 2015 Oct; 49(4):513-522.e1. PubMed ID: 25910824
[TBL] [Abstract][Full Text] [Related]
38. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
[TBL] [Abstract][Full Text] [Related]
39. Complementary and alternative pain therapy in the emergency department.
Dillard JN; Knapp S
Emerg Med Clin North Am; 2005 May; 23(2):529-49. PubMed ID: 15829396
[TBL] [Abstract][Full Text] [Related]
40. Neurological complications of sickle cell disease in Africa: protocol for a systematic review.
Mengnjo MK; Kamtchum-Tatuene J; Nicastro N; Noubiap JJ
BMJ Open; 2016 Oct; 6(10):e012981. PubMed ID: 27798028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
